| 000 | 01822 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516202207.0 | ||
| 264 | 0 | _c20141118 | |
| 008 | 201411s 0 0 eng d | ||
| 022 | _a1941-7705 | ||
| 024 | 7 |
_a10.1161/CIRCOUTCOMES.113.000799 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPletcher, Mark J | |
| 245 | 0 | 0 |
_aUsing the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis. _h[electronic resource] |
| 260 |
_bCirculation. Cardiovascular quality and outcomes _cMar 2014 |
||
| 300 |
_a276-84 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCalcium _xblood |
| 650 | 0 | 4 | _aComputer Simulation |
| 650 | 0 | 4 |
_aCoronary Disease _xdiagnosis |
| 650 | 0 | 4 |
_aCoronary Vessels _xmetabolism |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aDecision Making, Computer-Assisted |
| 650 | 0 | 4 | _aDrug Dosage Calculations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMass Screening |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMuscular Diseases _xetiology |
| 650 | 0 | 4 | _aPrimary Prevention |
| 650 | 0 | 4 | _aRadiation, Ionizing |
| 650 | 0 | 4 | _aTomography, X-Ray Computed |
| 700 | 1 | _aPignone, Michael | |
| 700 | 1 | _aEarnshaw, Stephanie | |
| 700 | 1 | _aMcDade, Cheryl | |
| 700 | 1 | _aPhillips, Kathryn A | |
| 700 | 1 | _aAuer, Reto | |
| 700 | 1 | _aZablotska, Lydia | |
| 700 | 1 | _aGreenland, Philip | |
| 773 | 0 |
_tCirculation. Cardiovascular quality and outcomes _gvol. 7 _gno. 2 _gp. 276-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/CIRCOUTCOMES.113.000799 _zAvailable from publisher's website |
| 999 |
_c23631097 _d23631097 |
||